← Open Payments lookup

STEPHANIE RIOLO: Open Payments

NPI 1942237425 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$510 in 22 payments from 10 companies in 2025. Trend: 2023 $6,648 · 2024 $87 · 2025 $510

Food & beverage: $510
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.5$191
Otsuka America Pharmaceutical, Inc.4$90
Janssen Pharmaceuticals, Inc3$58
Neurocrine BioSciences, Inc.3$49
Noven Therapeutics, LLC2$33
Teva Pharmaceuticals USA, Inc.1$25
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19
Orexo US, Inc.1$16
Supernus Pharmaceuticals, Inc.1$15
Takeda Pharmaceuticals U.S.A., Inc.1$14

Products named: COBENFY, REXULTI, INVEGA SUSTENNA, INGREZZA, Xelstrym, UZEDY, ABILIFY MAINTENA, CAPLYTA.

Industry payments across OH — which companies pay providers there.